Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term intensive insulin followed by metformin vs saxagliptin in newly diagnosed type 2 diabetes
ChiCTR-IPR-17011488Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Nov 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin, saxagliptin and insulin lispro in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Glycated hemoglobin (HbA1c), Blood glucose and 5 more. Started Nov 2015; status: recruiting.
02
Drugs
metforminsaxagliptininsulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17011488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011488.